Urologic Cancer

Our Cancer Specialties

Urologic Cancer Hospital in Banjara Hills, Hyderabad

Urologic cancers develop in the organs of the urinary system and the male reproductive tract. These cancers can affect the kidneys, urinary bladder, ureters, penis,urethra, and testes. Detecting these cancers at an early stage greatly improves treatment outcomes, especially in kidney and bladder cancers where symptoms may be mild or unnoticed in the beginning.

About Urologic Cancers

The most common urologic malignancies (excluding prostate) include:

Kidney Cancer
Bladder Cancer
Testicles Cancer
Upper Tract Urothelial & Ureter Tumors
Urethral
Genital ( vulva & penile) cancers

Early-stage urologic cancers are often highly treatable. Advanced cases require a combination of surgery and systemic therapies.

Symptoms of Urologic Cancer

Blood in urine (painless hematuria)

Flank or abdominal pain

Recurrent urinary infections

Difficulty urinating

Testicular swelling or painless lump

Non healing ulcer, skin changes or lump at the end of penis

Unexplained weight loss or fatigue

Diagnostic Evaluation

Ultrasound of abdomen or scrotum

Contrast-enhanced CT or MRI

Cystoscopy for bladder evaluation

Biopsy when indicated

Blood investigations including tumor markers (especially in testicular cancer)

Types of Urologic Cancers We Treat

Kidney Cancer

Partial or radical nephrectomy (kidney-preserving surgery whenever feasible)

Targeted therapy or immunotherapy in advanced disease including immune checkpoint inhibitors and targeted therapies:

Whenever feasible, partial nephrectomy (nephron-sparing surgery) is preferred for localized kidney tumors to preserve renal function without compromising oncologic safety. Minimally invasive and Image guided (RFA-Radio Frequency Ablation / Cryotherapy) approaches may be considered in selected cases.

Bladder Cancer

Transurethral resection (TURBT) for early-stage disease

Intravesical therapy( BCG/ chemotherapy)

Radical cystectomy for muscle-invasive disease

We also offer immunotherapy & Antibody-Based Treatment for advanced or metastatic urothelial carcinoma including Antibody-drug conjugates (ADCs)

PD-L1 testing and molecular profiling guide therapy selection in advanced cases.

Genital cancer

Early detection allows organ-preserving treatments with better functional outcomes

Advanced disease may require definitive surgical management including partial or total organ removal

Lymph node evaluation and dissections are performed when cancer spread is suspected

Multimodal treatment including chemotherapy, radiotherapy, hormonal therapy or targeted therapy may be recommended

Testicular Cancer

Radical inguinal orchiectomy

RPLND (Retroperitoneal Lymph Node Dissection)

Chemotherapy in selected cases

Surveillance protocols in early-stage low-risk tumors

Penile Cancer

Organ Preserving surgery for early stage , penectomy (partial or total) for locally advanced stages

Sentinel or inguinal lymph nodal dissections

Chemotherapy and Radiotherapy in selected cases

Stage-Based Overview

Localized disease

Surgery is often curative.

Locally advanced disease

Surgery with or without systemic therapy.

Metastatic disease

Systemic therapy including targeted agents or immunotherapy.

Multidisciplinary & Supportive Care

Management may involve:

Surgical oncology
Medical oncology
Urology specialists
Radiology and pathology
Rehabilitation and survivorship planning

Functional outcomes such as urinary control, renal preservation, and sexual health are carefully considered during treatment planning.

FAQ’s

Is blood in urine always cancer?

No. Infections, stones, and benign conditions can cause hematuria. However, any unexplained episode should be evaluated to rule out bladder or kidney cancer.
Can kidney cancer be treated without removing the entire kidney?
Is testicular cancer curable?
Do all bladder cancers require bladder removal?

Reviewed By

Medically Reviewed by : Dr. Srinivas Prasad, MCh (Surgical Oncology)
20+ years of experience in oncologic surgery and multidisciplinary cancer care.
Registration No: 2111
Last reviewed: February 2026